Bactericidal/permeability-increasing protein: clinical development and potential pediatric applications.
Giroir
B P
BP
Children's Medical Center of Dallas, University of Texas Southwestern Medical Center, Dallas, TX, USA.
D000328:Adult; D000818:Animals; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000494:pharmacology*; D023181:Antimicrobial Cationic Peptides; D016470:Bacteremia / Q000175:diagnosis / Q000188:drug therapy*; D001770:Blood Bactericidal Activity; D001798:Blood Proteins / Q000008:administration & dosage / Q000494:pharmacology*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D005500:Follow-Up Studies; D006801:Humans; D008565:Membrane Proteins; D010033:Otitis Media / Q000175:diagnosis / Q000188:drug therapy*; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index
D000890:Anti-Infective Agents; D023181:Antimicrobial Cationic Peptides; D001798:Blood Proteins; D008565:Membrane Proteins; C021623:bactericidal permeability increasing protein